FDA Accepts Bayer’s NDA for Elinzanetant to Treat Menopause Symptoms
The therapy’s Prescription Drug User Fee Act date has been set for July 26, 2025.
Conference Recap: CHEST 2024
This year’s annual meeting of the American College of Chest Physicians featured more than 300 educational sessions, insights from over 600 faculty members, and 29.5 hours of CE credits.
Exploring Challenges in Diagnosis, Treatment of Asthma-COPD Overlap Syndrome | CHEST 2024
Two posters presented at the annual meeting of the American College of Chest Physicians, CHEST 2024, offered insights into the accurate diagnosis and appropriate treatment of ACOS.
Examining the Impact of COVID-19 on Patients with Liver Disease
Research presented at CHEST 2024 examined outcomes of COVID-19 on patients with alcoholic liver disease, cirrhosis, and non-alcohol steatohepatitis.
Strategies for Success: How to Navigate the Evolving Health Care Landscape and Unlock Alternate Revenue Streams
Emily Endres, BSPS, vice president of pharmacy at PQS by Innovaccer, provides insights into the industry’s next phase.
Texas Sues Multiple PBMs, Drug Manufacturers Over Inflated Insulin Prices
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.
Assessing the Efficacy of Mepolizumab in Asthma, COPD
Research Presented at CHEST 2024 reported on how mepolizumab can improve asthma control, and reduce exacerbations of concurrent asthma and COPD.
The Perils of Frivolous Lawsuits
Current rules governing lawsuits must be revisited to strike a balance between legitimate and frivolous legal actions against health care providers.
5 Questions With a Pharmacist: Anthony Minniti from Bell Pharmacy
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Anthony Minniti of Bell Pharmacy in Camden, New Jersey, discussed pharmacy in his community and the challenges that come with it.
An Independent Pharmacist’s Journey to Championing Community Care
Drug Topics sat down with Benjamin Jolley, PharmD, of Jolley’s Compounding Pharmacy, to discuss the pharmacy industry and his experience in a myriad of roles within the profession.
Use MTM and Patient Engagement Solutions to Increase Profits
Adherence interventions and comprehensive reviews can reduce health care costs, boost revenue, and improve patient outcomes.
FDA Grants Marketing Authorization to First OTC Flu, COVID-19 Combination Test
The Healgen Rapid Check COVID-19/Flu A&B Antigen Test is the first at-home test to be granted marketing authorization using a traditional premarket review pathway.
Kentucky Sues Express Scripts for Role in Opioid Crisis
The 70-plus-page lawsuit is directed at Express Scripts for its dealings with drug manufacturers in fueling the US opioid crisis.
Florida Pharmacist Discusses Medication Preparedness for Hurricanes
Florida-based pharmacist Brad Phillips, PharmD, BCACP, speaks to the importance of pre-planning, emergency refills, medication storage, and post-storm safety measures to ensure medication security during hurricanes.
Medication Therapy Management: Improving Patient Outcomes and Pharmacy Income
Medication therapy management can change the trajectory of patient health outcomes. Here is how pharmacists can ensure adherence and compensation.
Prednisone Superior to Other Corticosteroids for Patients with COPD, Heart Failure
Research presented at CHEST 2024 examined the effect of steroid choice on individuals who have a dual diagnosis of heart failure and COPD.
COVID-19 Infection Raises Heart Failure Risks, Underlines Vaccination Importance
Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.
Midyear Pharmacy Update: Evaluating the Impact of DIR Fees
A roundtable session discussed the real-world implications of applying DIR fees at the point of sale rather than through retroactive clawback.
In This Issue: Total Pharmacy October 2024
See what’s trending in pharmacy with a preview of the Total Pharmacy October issue.
AstraZeneca’s Airsupra Significantly Reduces Risk of Severe Exacerbations in Patients with Asthma
The company will be presenting the full BATURA study data as a late-breaker oral presentation at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting.
OTC Product Roundup: Topical Analgesics
Whether patients present with complaints of an aching muscle from a workout or a sudden twinge in the back, consider recommending these topical analgesics.
American Pharmacists Month Shines a Spotlight on Community Caregiving
Examining Barriers to Assessing and Treating Pain in Pediatric Patients
Although there has recently been an effort to improve pediatric pain treatment, it is still often underestimated and not adequately managed.
Weekend ICYMI: September 30 to October 4
In case you missed it, this week we had stories about the availability of the first liquid nonstimulant for ADHD, pharmacy technicians as "vaccine champions," SGLT2i's heart-healthy benefits, and more.
Now Trending: Breast Cancer Awareness Month, Vaccine Hesitancy
Check out this recap of articles published on our sister sites during the past week.
Small Doses: September 30 to October 4
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
FDA Approves New Non-Invasive Colorectal Cancer Screening Test
Cologuard Plus is approved for adults aged 45 years and older who are at average risk for the disease.
Beyond Blood Glucose: Addressing Adolescent Diabetes Challenges
Social pressures, physiological changes, mental health challenges, and burnout all complicate diabetes management among adolescents.
Multimodal Approach Suggested for Treating Pain Amongst Adolescents
Researchers aimed to determine whether or not opioids were appropriate for treating adolescents experiencing chronic pain.
FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation
Check out important updates from the FDA for the week of September 30.
